1. Home
  2. BA vs NVO Comparison

BA vs NVO Comparison

Compare BA & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boeing Company (The)

BA

Boeing Company (The)

HOLD

Current Price

$247.23

Market Cap

144.1B

Sector

Industrials

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$62.02

Market Cap

212.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BA
NVO
Founded
1916
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.1B
212.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BA
NVO
Price
$247.23
$62.02
Analyst Decision
Strong Buy
Hold
Analyst Count
19
10
Target Price
$245.42
$54.25
AVG Volume (30 Days)
7.0M
20.8M
Earning Date
01-27-2026
02-04-2026
Dividend Yield
N/A
1.97%
EPS Growth
N/A
10.06
EPS
N/A
3.67
Revenue
$80,757,000,000.00
$49,580,393,058.00
Revenue This Year
$36.46
$7.25
Revenue Next Year
$10.20
$0.24
P/E Ratio
N/A
$16.45
Revenue Growth
10.18
16.64
52 Week Low
$128.88
$43.08
52 Week High
$248.75
$93.80

Technical Indicators

Market Signals
Indicator
BA
NVO
Relative Strength Index (RSI) 78.24 72.64
Support Level $239.60 $56.29
Resistance Level $248.75 $60.63
Average True Range (ATR) 5.41 1.44
MACD 1.85 0.59
Stochastic Oscillator 94.52 96.28

Price Performance

Historical Comparison
BA
NVO

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: